Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Celldex Therapeutics (CLDX) Return on Invested Capital (2018 - 2021)

Celldex Therapeutics has reported Return on Invested Capital over the past 3 years, most recently at 0.04% for Q4 2021.

  • Quarterly results put Return on Invested Capital at 0.04% for Q4 2021, up 26.0% from a year ago — trailing twelve months through Dec 2021 was 0.04% (up 26.0% YoY), and the annual figure for FY2021 was 0.05%, up 36.0%.
  • Return on Invested Capital for Q4 2021 was 0.04% at Celldex Therapeutics, up from 0.25% in the prior quarter.
  • Over the last five years, Return on Invested Capital for CLDX hit a ceiling of 0.03% in Q2 2020 and a floor of 1.29% in Q2 2018.
  • Median Return on Invested Capital over the past 3 years was 0.27% (2021), compared with a mean of 0.54%.
  • Peak annual rise in Return on Invested Capital hit 26bps in 2021, while the deepest fall reached -22bps in 2021.
  • Celldex Therapeutics' Return on Invested Capital stood at 1.23% in 2018, then surged by 76bps to 0.29% in 2020, then skyrocketed by 88bps to 0.04% in 2021.
  • The last three reported values for Return on Invested Capital were 0.04% (Q4 2021), 0.25% (Q3 2021), and 0.29% (Q4 2020) per Business Quant data.